Samip Master is an Oncology physician. OpenAlex indexes 107 publications with 476 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
501 W Medical Center Blvd
Webster, TX 775984219
Telephone
281-332-7505Provider last certified this registry record 27 Aug 2025.
Industry payments
57 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20258 payments
- ABBVIE INC.Program year202515 payments
- Novartis Pharmaceuticals CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
28.1%Corticosteroid12.4%Prednisone100%Part D≥24 patientsSerotonin-3 Receptor Antagonist8.8%Ondansetron Odt100%Part D≥45 patients+ 2 more classes in this area
Respiratory
19.7%Opioid Agonist15.4%Hydrocodone-Acetaminophen100%Part D≥26 patientsPhenothiazine4.3%Promethazine Hcl100%Part D≥23 patientsNervous system
17.2%Opioid Agonist12.5%Oxycodone Hcl38%Morphine Sulfate Er34%Morphine Sulfate14%Oxycodone-Acetaminophen13%Part D<11 patientsAtypical Antipsychotic2.5%Olanzapine100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Management recommendations for kidney transplantation in patients with plasma cell dyscrasia
Kidney International
2025 - When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy
International Journal of Molecular Sciences
2025 - Cardiovascular complications associated with asciminib use: A retrospective analysis.
Journal of Clinical Oncology
2024 - Impact of scheduled partial exchange transfusions on outcomes in pregnant patients with severe sickle cell disease: a retrospective study
Hematology Transfusion and Cell Therapy
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”